Table of Contents
2019-2024 Global Therapeutic Radiopharmaceuticals Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Radiopharmaceuticals Consumption 2014-2024
2.1.2 Therapeutic Radiopharmaceuticals Consumption CAGR by Region
2.2 Therapeutic Radiopharmaceuticals Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radiopharmaceuticals Consumption by Type
2.3.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
2.3.2 Global Therapeutic Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
2.3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Type (2014-2019)
2.4 Therapeutic Radiopharmaceuticals Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radiopharmaceuticals Consumption by Application
2.5.1 Global Therapeutic Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
2.5.2 Global Therapeutic Radiopharmaceuticals Value and Market Share by Application (2014-2019)
2.5.3 Global Therapeutic Radiopharmaceuticals Sale Price by Application (2014-2019)
3 Global Therapeutic Radiopharmaceuticals by Players
3.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players
3.1.1 Global Therapeutic Radiopharmaceuticals Sales by Players (2017-2019)
3.1.2 Global Therapeutic Radiopharmaceuticals Sales Market Share by Players (2017-2019)
3.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players
3.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Players (2017-2019)
3.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
3.3 Global Therapeutic Radiopharmaceuticals Sale Price by Players
3.4 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Therapeutic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Therapeutic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Therapeutic Radiopharmaceuticals by Regions
4.1 Therapeutic Radiopharmaceuticals by Regions
4.1.1 Global Therapeutic Radiopharmaceuticals Consumption by Regions
4.1.2 Global Therapeutic Radiopharmaceuticals Value by Regions
4.2 Americas Therapeutic Radiopharmaceuticals Consumption Growth
4.3 APAC Therapeutic Radiopharmaceuticals Consumption Growth
4.4 Europe Therapeutic Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
5.1.2 Americas Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
5.2 Americas Therapeutic Radiopharmaceuticals Consumption by Type
5.3 Americas Therapeutic Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries
6.1.1 APAC Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
6.1.2 APAC Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
6.2 APAC Therapeutic Radiopharmaceuticals Consumption by Type
6.3 APAC Therapeutic Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Therapeutic Radiopharmaceuticals by Countries
7.1.1 Europe Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
7.1.2 Europe Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
7.2 Europe Therapeutic Radiopharmaceuticals Consumption by Type
7.3 Europe Therapeutic Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Therapeutic Radiopharmaceuticals Value by Countries (2014-2019)
8.2 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Therapeutic Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Radiopharmaceuticals Distributors
10.3 Therapeutic Radiopharmaceuticals Customer
11 Global Therapeutic Radiopharmaceuticals Market Forecast
11.1 Global Therapeutic Radiopharmaceuticals Consumption Forecast (2019-2024)
11.2 Global Therapeutic Radiopharmaceuticals Forecast by Regions
11.2.1 Global Therapeutic Radiopharmaceuticals Forecast by Regions (2019-2024)
11.2.2 Global Therapeutic Radiopharmaceuticals Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Therapeutic Radiopharmaceuticals Forecast by Type
11.8 Global Therapeutic Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Therapeutic Radiopharmaceuticals Product Offered
12.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 Novartis
12.2.1 Company Details
12.2.2 Therapeutic Radiopharmaceuticals Product Offered
12.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Novartis News
12.3 China Isotope & Radiation
12.3.1 Company Details
12.3.2 Therapeutic Radiopharmaceuticals Product Offered
12.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 China Isotope & Radiation News
12.4 Dongcheng
12.4.1 Company Details
12.4.2 Therapeutic Radiopharmaceuticals Product Offered
12.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Dongcheng News
12.5 Q BioMed
12.5.1 Company Details
12.5.2 Therapeutic Radiopharmaceuticals Product Offered
12.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Q BioMed News
12.6 Curium Pharmaceuticals
12.6.1 Company Details
12.6.2 Therapeutic Radiopharmaceuticals Product Offered
12.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Curium Pharmaceuticals News
12.7 Jubilant DraxImage
12.7.1 Company Details
12.7.2 Therapeutic Radiopharmaceuticals Product Offered
12.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Jubilant DraxImage News
12.8 Lantheus
12.8.1 Company Details
12.8.2 Therapeutic Radiopharmaceuticals Product Offered
12.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Lantheus News
12.9 Spectrum Pharmaceuticals
12.9.1 Company Details
12.9.2 Therapeutic Radiopharmaceuticals Product Offered
12.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Spectrum Pharmaceuticals News
12.10 Progenics Pharmaceuticals
12.10.1 Company Details
12.10.2 Therapeutic Radiopharmaceuticals Product Offered
12.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Progenics Pharmaceuticals News
12.11 International Isotopes
13 Research Findings and Conclusion
